Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK7 | P50613 | 2/20 | 0.39 |
| ▸ | CDK2 | P24941 | 10/20 | 0.39 |
| ▸ | FLT3 | P36888 | 9/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 8/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 5/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26246793 | 0.92 | PDE4B (0.41) | CYP2C19HTR6DRD2HTR2ADRD3 | |
| SCHEMBL2273309 | 0.91 | ITK (0.38) | CYP2C19HTR6GSK3BDRD2HTR2A | |
| SCHEMBL29809747 | 0.91 | PDE4B (0.43) | CYP2C19HTR6DRD2HTR2ACDK1 | |
| SCHEMBL2222165 | 0.91 | PDE4B (0.43) | CYP2C19HTR6DRD2HTR2ACDK1 | |
| SCHEMBL2278291 | 0.90 | CYP2C19 (0.39) | CYP2C19HTR6DRD2HTR2ADRD3 | |
| SCHEMBL10281621 | 0.89 | HTR6 (0.47) | CYP2C19HTR6DRD2HTR2ADRD3 | |
| SCHEMBL25235508 | 0.88 | CYP2C19 (0.36) | CYP2C19HTR6DRD2HTR2ADRD3 | |
| SCHEMBL30480438 | 0.88 | CYP2C19 (0.36) | CYP2C19HTR6DRD2HTR2ADRD3 | |
| SCHEMBL2222679 | 0.88 | CYP2C19 (0.36) | CYP2C19HTR6DRD2HTR2ADRD3 | |
| SCHEMBL2278296 | 0.87 | CYP2C19 (0.37) | CYP2C19HTR6DRD2HTR2ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013007765-A1 | FUSED TRICYCLIC COMPOUNDS FOR USE AS INHIBITORS OF JANUS KINASES | F. HOFFMANN-LA ROCHE AG (CH) | 2013-01-17 | — | — | WO | disclosed |